Hytest
Immunological reagents, antibodies and antigens for IVD manufacturers and research labs
Highlights
- New on EvolcAdded 2026-10-30
About Hytest
HyTest (Hytest Oy) develops and supplies immunological reagents, including monoclonal and polyclonal antibodies, antigens, and sera and plasma, for in vitro diagnostics (IVD) and research. Product areas include cardiac markers, inflammation markers, blood coagulation and anemia, infectious diseases and neuroscience markers.
Customers are industrial IVD companies and research institutions. Products are sold as raw materials, ordered through an online store or by quote, and the company offers technical support and product documentation.
The company was founded in 1994 and is headquartered in Turku, Finland. It has a subsidiary in Shanghai, China, operating since 2011, and a fully owned subsidiary, Hytest Russia, established in 2016. Its operations are ISO 9001 certified.
Product: Monoclonal and polyclonal antibodies, antigens, and sera and plasma for immunoassay development and diagnostic testing.
Jobs at Hytest
Leadership
- Netta Keinänen · CEOSource: company website
- Michael Berman · CFOSource: company website
- Soozy Xi · CCOSource: company website
- Daria Talikova · HR DirectorSource: company website
More biotech & pharma companies
KÄÄPÄ BioTech
Standardised functional mushroom extracts for pharmaceutical, nutraceutical and wellness product developersNew on EvolcKaro Healthcare
Consumer healthcare company marketing everyday health products in over 90 markets, mainly Europe and the Nordic countriesNew on EvolcKRKA Finland
Markets prescription medicines, over-the-counter products and veterinary medicines to customers in FinlandNew on EvolcLabema
Distributor of microbiology, hygiene and rapid diagnostic test products for labs in food, healthcare and water sectors in FinlandNew on EvolcLeo Pharma
Develops and supplies medicines for skin diseases and selected critical-care conditions to patients worldwideNew on Evolc
Website technologies
Older, unverified list. Detection dates and supporting evidence are not yet available.
- AWS
- Cloudflare
- Cookiebot
- Google Ads
- Google Tag Manager
- Google Universal Analytics
- Google reCAPTCHA
- Hotjar
- Intercom
- LinkedIn Insight
- Meta Pixel
- Ruby on Rails
- VWO
- jQuery
- nginx